SYN-Tech Chem & Pharm Co Ltd Asset Resilience Ratio

Latest as of June 2023: 0.42%

SYN-Tech Chem & Pharm Co Ltd asset resilience ratio. SYN-Tech Chem & Pharm Co Ltd (1777) has an Asset Resilience Ratio of 0.42% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SYN-Tech Chem & Pharm Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

NT$12.09 Million
≈ $380.78K USD Cash + Short-term Investments

Total Assets

NT$2.90 Billion
≈ $91.48 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of SYN-Tech Chem & Pharm Co Ltd (2015–2022)

Asset resilience ratio of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2022. This chart shows how SYN-Tech Chem & Pharm Co Ltd's Asset Resilience Ratio has changed over time. Read SYN-Tech Chem & Pharm Co Ltd (1777) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down SYN-Tech Chem & Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 1777 current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$12.09 Million 0.42%
Total Liquid Assets NT$12.09 Million 0.42%

Asset Resilience Insights

  • Limited Liquidity: SYN-Tech Chem & Pharm Co Ltd maintains only 0.42% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

SYN-Tech Chem & Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare SYN-Tech Chem & Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Biotechnology 62.31%
Verona Pharma plc
F:I9SA
Biotechnology 0.00%
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
Biotechnology 33.37%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
Biotechnology 8.08%
Bavarian Nordic
CO:BAVA
Biotechnology 10.83%
Hebei Changshan Biochem Pharma
SHE:300255
Biotechnology -0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
Biotechnology 37.31%

SYN-Tech Chem & Pharm Co Ltd Asset Resilience Ratio by Year (2015–2022)

SYN-Tech Chem & Pharm Co Ltd asset resilience ratio by year from 2015 to 2022. The table below shows the annual Asset Resilience Ratio data for SYN-Tech Chem & Pharm Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 4.29% NT$119.16 Million
≈ $3.75 Million
NT$2.78 Billion
≈ $87.57 Million
-4.66pp
2021-12-31 8.95% NT$259.09 Million
≈ $8.16 Million
NT$2.90 Billion
≈ $91.21 Million
+0.64pp
2019-12-31 8.31% NT$154.60 Million
≈ $4.87 Million
NT$1.86 Billion
≈ $58.63 Million
-6.69pp
2018-12-31 15.00% NT$273.63 Million
≈ $8.62 Million
NT$1.82 Billion
≈ $57.49 Million
-5.77pp
2017-12-31 20.77% NT$323.16 Million
≈ $10.18 Million
NT$1.56 Billion
≈ $49.02 Million
+20.56pp
2016-12-31 0.21% NT$2.73 Million
≈ $85.85K
NT$1.29 Billion
≈ $40.56 Million
-4.53pp
2015-12-31 4.74% NT$58.00 Million
≈ $1.83 Million
NT$1.22 Billion
≈ $38.57 Million
--
pp = percentage points

About SYN-Tech Chem & Pharm Co Ltd

TWO:1777 Taiwan Biotechnology
Market Cap
$108.60 Million
NT$3.45 Billion TWD
Market Cap Rank
#18708 Global
#1028 in Taiwan
Share Price
NT$77.30
Change (1 day)
+0.13%
52-Week Range
NT$70.30 - NT$78.80
All Time High
NT$108.00
About

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relax… Read more